reaminated to leucine or it may leave the
cell. Because KIC is only found in the cell
from leucine transamination, plasma KIC
reflects the intracellular KIC enrichment
and can be used as an index of intracellular
leucine tracer enrichment. This approach
expands the single-pool model into a four-
pool model. The calculations are made by
substituting the leucine isotopic enrich-
ment for the KIC enrichment (Fig. 2.7).
This approach is commonly called the
‘reciprocal-pool’ approach (measurement
of the tracer in the metabolite opposite to
the infused) (Schwenk et al., 1985). There
are still drawbacks that remain: (i) there are
still multiple intracellular sites in the body,
and it is not known what contribution they
make to plasma KIC, and (ii) there are a
variety of proteins in the body turning over
at different rates.
Finally, Cobelli et al. (1991) designed a
ten-compartment model, which involves
simultaneously infusing dual tracers of
leucine and KIC and measuring the result-
ing four enrichment curves in plasma and
one in expired air. This model accounted
for the complexity of the leucine system,
but the authors failed to adopt a multi-
tissue scheme for slow and fast kinetic
events (liver as compared with muscle).
These data demonstrated that there was no
single intracellular pool for leucine and
KIC. However, this model is mathematically
difficult and is not solved easily. This
model has not been used in an experimental
design where protein metabolism is altered.
Its value may be to test the structural errors
of simpler but commonly used models.
Measurement of Tissue Protein
Metabolism in Vivo
Currently, protein synthesis can be
measured directly by two approaches
(Garlick et al., 1994; Rennie et al., 1994), i.e.
constant infusion or the ‘flooding dose’ of a
labelled amino acid. The fractional rate of
synthesis of a protein or mixture of proteins
can be measured from an estimate of the
change in incorporation of a labelled amino
acid into protein over time in tissues.
Measurement and Significance of Protein Turnover 31
Protein
B S
I C
Leucine
Protein
S B
[1^13 C]KIC
[1^13 C]Leucine
[1^13 C]Leucine
[1^13 C]KIC
(^13) CO 2
Isovaleryl CoA
Tracer Infusion
([1^13 C]leucine)
Intracellular Plasma
Fig. 2.6.Original model for leucine kinetics of an
essential amino acid and its relationship to protein
turnover. B = breakdown; S = synthesis (non-
oxidative disposal); I = dietary intake; C =
oxidation. Under steady-state conditions, leucine
flux is Q = I + B = S + C. When I = O (post-
absorptive), B = Q. Whole-body synthesis is
calculated as S = Q C.
Fig. 2.7.The current model of whole-body
synthesis of [1^13 C]leucine. The infused tracer
reached an equilibrium with intracellular leucine
and KIC. The use of plasma KIC enrichment allows
for the calculation of the total intracellular rate of
appearance and the correct calculation of leucine
oxidation. Breakdown (B) = F/[1^13 C]KIC
enrichment; oxidation (C) =^13 CO 2 /[1^13 C]KIC
enrichment; synthesis (S) = B C.